Skip to main content
Clinical Trials/NCT06159192
NCT06159192
Recruiting
Not Applicable

Monitoring Effect Of Shock Wave On Microcirculation Changes In Type2 Diabetes Mellitus

South Valley University1 site in 1 country80 target enrollmentMarch 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Shock Wave and Nitric Oxide
Sponsor
South Valley University
Enrollment
80
Locations
1
Primary Endpoint
• Numerical Rating Pain Scale
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of the study is to monitor the effect of low intensity extracorporeal shock wave therapy on impaired nitric oxide synthase and microcirculation changes in type 2 diabetes mellitus with peripheral neuropathy.

Detailed Description

Low-intensity extracorporeal shockwave therapy (Li-ESWT) improved peripheral nerve repair and regeneration. Li-ESWT exerts its biological effects by increasing neuro¬trophic factors, Schwann cell activation, and cellular signaling activation. Li-ESWT could be a novel treatment for nerve injury-induced diabetic neuropathy and other conditions related to nerve in¬jury.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
April 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ibrahim Abuzaid

Head of the Department of Physiotherapy for Cardiovascular/ Rspiratory disorder and Geriatrics

South Valley University

Eligibility Criteria

Inclusion Criteria

  • Patients have to be symptomatically stable with type 2 diabetes mellitus complicated with peripheral neuropathy.
  • Optimized pharmacological treatment that will be remained unchanged throughout the study.

Exclusion Criteria

  • Implanted cardiac pacemakers.
  • Patients with known skin allergies.
  • Presence of skin inflammations.
  • Peripheral vascular disease.
  • Patients with unstable angina pectoris.
  • Progressive ventricular dysrhythmia.
  • Intermittent claudication.

Outcomes

Primary Outcomes

• Numerical Rating Pain Scale

Time Frame: six weeks

• The Numerical Rating Scale (NRS) is designed for anyone over age 9. It is one of the most commonly used pain scales in health care. To use it, you just say the number that best matches the level of pain you are feeling; you can also place a mark on the scale itself. Zero means you have no pain, while 10 represents the most intense pain possible.

• Nitric oxide level and electrophysiological investigations of peripheral nerves and muscles was measured pre and post treatment.

Time Frame: six weeks

1. Laboratory methods: Nitric oxide laboratories for measurement of nitric oxide level.3. Electrodiagnostic studies are sensitive, specific, and validated measures of the presence of polyneuropathy.

Study Sites (1)

Loading locations...

Similar Trials